JP2018526403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526403A5 JP2018526403A5 JP2018512407A JP2018512407A JP2018526403A5 JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5 JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- antibody
- intestinal wall
- item
- penetrating member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021125408A JP2021169530A (ja) | 2015-09-08 | 2021-07-30 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562215586P | 2015-09-08 | 2015-09-08 | |
| US62/215,586 | 2015-09-08 | ||
| US15/150,379 | 2016-05-09 | ||
| US15/150,379 US11548940B2 (en) | 2014-05-15 | 2016-05-09 | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| PCT/US2016/050832 WO2017044665A1 (en) | 2015-09-08 | 2016-09-08 | Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021125408A Division JP2021169530A (ja) | 2015-09-08 | 2021-07-30 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018526403A JP2018526403A (ja) | 2018-09-13 |
| JP2018526403A5 true JP2018526403A5 (https=) | 2019-10-03 |
Family
ID=58240088
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018512407A Withdrawn JP2018526403A (ja) | 2015-09-08 | 2016-09-08 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
| JP2021125408A Pending JP2021169530A (ja) | 2015-09-08 | 2021-07-30 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
| JP2023084891A Pending JP2023104992A (ja) | 2015-09-08 | 2023-05-23 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021125408A Pending JP2021169530A (ja) | 2015-09-08 | 2021-07-30 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
| JP2023084891A Pending JP2023104992A (ja) | 2015-09-08 | 2023-05-23 | 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3347050B1 (https=) |
| JP (3) | JP2018526403A (https=) |
| CN (1) | CN108401419A (https=) |
| AU (2) | AU2016320867B2 (https=) |
| CA (1) | CA2997958A1 (https=) |
| DK (1) | DK3347050T3 (https=) |
| WO (1) | WO2017044665A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| EP3142645A4 (en) | 2014-05-15 | 2017-12-27 | Rani Therapeutics, LLC | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| WO2018213579A1 (en) | 2017-05-17 | 2018-11-22 | Massachusetts Institute Of Technology | Self-actuating articles |
| US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| AU2019269636A1 (en) | 2018-05-17 | 2020-11-19 | Massachusetts Institute Of Technology | Systems for electrical stimulation |
| US12128133B2 (en) | 2018-09-25 | 2024-10-29 | Rani Therapeutics, Llc | Ingestible device with expandable enclosure |
| CN117100683A (zh) * | 2018-12-31 | 2023-11-24 | 拉尼医疗有限公司 | 使用可吞服药物递送装置递送到肠道内腔的治疗剂制剂 |
| EP4696361A3 (en) | 2019-02-01 | 2026-04-15 | Massachusetts Institute of Technology | Systems and methods for liquid injection |
| EP3962516B1 (en) * | 2019-05-03 | 2026-04-29 | Rani Therapeutics, LLC | Clotting factor viii preparations for delivery through tissue of the intestinal tract using a swallowable drug delivery device |
| US11541216B2 (en) | 2019-11-21 | 2023-01-03 | Massachusetts Institute Of Technology | Methods for manufacturing tissue interfacing components |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2785168C (en) * | 2009-12-24 | 2018-04-17 | Incube Labs, Llc | Swallowable drug delivery device and methods of drug delivery |
| US8721620B2 (en) * | 2009-12-24 | 2014-05-13 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
| US9149617B2 (en) * | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| ES2773115T3 (es) * | 2011-06-29 | 2020-07-09 | Rani Therapeutics Llc | Preparados de agentes terapéuticos para la administración hacia el interior de una luz del tubo intestinal utilizando un dispositivo tragable para la administración de fármacos |
| PT3653223T (pt) * | 2011-06-29 | 2021-12-06 | Rani Therapeutics Llc | Dispositivo para a entrega oral de compostos terapêuticos |
| CN104093423A (zh) | 2011-07-14 | 2014-10-08 | 辉瑞公司 | 使用抗pcsk9抗体的治疗 |
| CN106029096A (zh) | 2014-02-14 | 2016-10-12 | 瑞泽恩制药公司 | 用于治疗具有未被中等剂量他汀疗法充分控制的高胆固醇血症的患者的方法 |
| AU2016261599B2 (en) * | 2015-05-08 | 2021-08-26 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
-
2016
- 2016-09-08 WO PCT/US2016/050832 patent/WO2017044665A1/en not_active Ceased
- 2016-09-08 EP EP16845073.2A patent/EP3347050B1/en active Active
- 2016-09-08 JP JP2018512407A patent/JP2018526403A/ja not_active Withdrawn
- 2016-09-08 CN CN201680065019.1A patent/CN108401419A/zh active Pending
- 2016-09-08 CA CA2997958A patent/CA2997958A1/en active Pending
- 2016-09-08 DK DK16845073.2T patent/DK3347050T3/da active
- 2016-09-08 AU AU2016320867A patent/AU2016320867B2/en not_active Ceased
-
2021
- 2021-07-30 JP JP2021125408A patent/JP2021169530A/ja active Pending
-
2023
- 2023-05-23 JP JP2023084891A patent/JP2023104992A/ja active Pending
- 2023-06-29 AU AU2023204153A patent/AU2023204153A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018526403A5 (https=) | ||
| AU2020256337B2 (en) | Dosing regimens for echinocandin class compounds | |
| JP4489356B2 (ja) | 浸透促進剤 | |
| JP6527497B2 (ja) | Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復 | |
| AU718971C (en) | Colonic delivery of nicotine to treat inflammatory bowel disease | |
| JP2005506367A5 (https=) | ||
| US20070292512A1 (en) | Solid Oral Dosage Form Containing an Enhancer | |
| Singh et al. | Pulsatile drug delivery system: an approach of medication according to circadian rhythm | |
| CN101277684A (zh) | 至少一种活性成分改善释放的微粒及含有该微粒的口服药物剂型 | |
| US20110218246A1 (en) | Methods of treating non-nociceptive pain states with gastric retentive gabapentin | |
| JP2023120445A (ja) | テルリプレシン組成物およびその使用方法 | |
| JP2005528430A5 (https=) | ||
| Gupta et al. | Old drugs, new delivery systems in Parkinson’s disease | |
| WO2021145436A1 (ja) | 目的とする既知の薬剤又はその等価物質の新たな適応症の予測方法、予測装置、及び予測プログラム | |
| JP2016530279A (ja) | 新規２，４−ジニトロフェノール製剤およびその使用法 | |
| JP2018520995A5 (https=) | ||
| NZ787785A (en) | Delayed release deferiprone tablets and methods of using the same | |
| JP2024504555A (ja) | 急性膵炎を予防及び治療するための薬物の製造におけるノルハルマンの使用 | |
| KR20140121394A (ko) | 아캄프로세이트 제제, 그것의 사용 방법, 및 그것을 포함하는 조합 | |
| JPWO2020186121A5 (https=) | ||
| WO2014176417A1 (en) | Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system | |
| JP2019517490A (ja) | がん療法のためのメトロノミック経口ゲムシタビン | |
| JP4370054B2 (ja) | 腸粘膜傷害の予防及び治療剤 | |
| Pandey et al. | Innovative approaches in HELICOBACTER pylori therapy: Clinical trials and advancements in Gastro-Retentive drug delivery systems | |
| RU2401112C2 (ru) | Фармацевтическая композиция для лечения аутоиммунных заболеваний, связанных с повышенным образованием антител к нуклеиновым кислотам |